MedPath
HSA Approval

MIDAZOLAM-BAXTER SOLUTION FOR INJECTION 5 MG/ML

SIN15419P

MIDAZOLAM-BAXTER SOLUTION FOR INJECTION 5 MG/ML

MIDAZOLAM-BAXTER SOLUTION FOR INJECTION 5 MG/ML

February 8, 2018

BAXTER HEALTHCARE (ASIA) PTE LTD

BAXTER HEALTHCARE (ASIA) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBAXTER HEALTHCARE (ASIA) PTE LTD
Licence HolderBAXTER HEALTHCARE (ASIA) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

INTRAVENOUS, INTRAMUSCULAR, RECTAL

Medical Information

N05CD08

midazolam

Manufacturer Information

BAXTER HEALTHCARE (ASIA) PTE LTD

Baxter Pharmaceuticals India Private Limited

Active Ingredients

Midazolam HCl 5.56 mg eqv Midazolam

5mg/ml

Midazolam

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MIDAZOLAM-BAXTER SOLUTION FOR INJECTION 5 MG/ML - HSA Approval | MedPath